Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2005
12/15/2005US20050277157 diagnosis or prognosis by detecting increased levels of markers that include ribosomal protein L7, beta -transducin, 1-TRAF (also known as TANK) or lysyl-tRNA synthetase, or antibodies against these antigens
12/15/2005US20050277156 Useful as diagnostic markers for cardiac diseases and/or pathology
12/15/2005US20050277154 Combinatorial complex carbohydrate libraries and methods for the manufacture and uses thereof
12/15/2005US20050277151 NTR3, a novel member of the TNF- receptor supergene family
12/15/2005US20050277150 Compositions and methods for identifying agents which regulate autolytic processes in bacteria
12/15/2005US20050277143 Formed by fusing a pinanediol bound to a solid support with a boronic or boric acid bound to a biomolecule; an array may be constructed by preparing the conjugate at a plurality of spatially distinct reaction sites on the solid support
12/15/2005US20050277142 Recombinant cell line for the detection of dioxin-like compounds based on the expression of luciferase gene
12/15/2005US20050277138 Reactive functional groups
12/15/2005US20050277126 Cytokine receptor chain
12/15/2005US20050277123 Variants of NEDD4L associated with hypertension and viral budding
12/15/2005US20050277115 Corynebacterium glutamicum genes encoding proteins involved in homeostasis and adaptation
12/15/2005US20050276821 Antigen protein and nucleic acid coding for said protein
12/15/2005US20050276820 structural modification alters the biological persistence, preferably the biological half-life
12/15/2005US20050276819 Helicobacter pylori CAI antigen
12/15/2005US20050276818 Uncharacterized ORF3 in SARS-coronavirus is a cyclic-AMP-dependent kinase and a target for SARS therapy
12/15/2005US20050276816 Infectious DNA as a vaccine against west nile and other flavivirues
12/15/2005US20050276814 Streptococcus pneumoniae proteins and nucleic acid molecules
12/15/2005US20050276808 Administering an effective amount of a vascular endothelial growth factor (VEGF) trap antagonist, renal cell carcinoma, pancreatic carcinoma, breast cancer, prostate cancer, colorectal cancer, malignant mesothelioma, multiple myeloma, ovarian cancer, and melanoma
12/15/2005US20050276804 Method for preventing or treating cardiac hypertrophy
12/15/2005US20050276787 Adeno-associated vector compositions for expression of factor VIII
12/15/2005US20050274924 Nucleic acid sequences encoding type III Tenebrio antifreeze proteins and method for assaying activity
12/15/2005CA2742088A1 Antibodies that bind psca proteins for diagnosis of cancer
12/15/2005CA2608003A1 Medical uses of carrier conjugates of non-human tnf-peptides
12/15/2005CA2569509A1 Anti-cd3 antibodies and methods of use thereof
12/15/2005CA2569095A1 Crystal structure of dipeptidyl peptidase iv (dpp-iv) and uses thereof
12/15/2005CA2568967A1 Agents and methods for diagnosing stress
12/15/2005CA2568838A1 Nucleic acids, polypeptides, methods of expression, and immunogenic compositions associated with sars corona virus spike protein
12/15/2005CA2568781A1 Intrathymic administration of viral vectors for the induction of immune tolerance, the prevention or treatment of immunodeficiencies or autoimmune diseases
12/15/2005CA2568772A1 Expression system based on recombinant vesicular stomatitis virus synthesizing t7 rna polymerase
12/15/2005CA2568750A1 Compositions and methods for treatment of neovascular diseases
12/15/2005CA2568642A1 Cynomolgus prostate specific antigen
12/15/2005CA2568367A1 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics
12/15/2005CA2568347A1 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics
12/15/2005CA2568345A1 Inhibitors of regiii proteins as asthma therapeutics
12/15/2005CA2568222A1 Plants having improved growth characteristics and a method for making the same
12/15/2005CA2568218A1 Multiple agent therapy for sexual dysfunction
12/15/2005CA2568161A1 A novel human card-only protein that inhibits pro-il-1beta maturation
12/15/2005CA2568026A1 Generation of plants with altered oil content
12/15/2005CA2568017A1 Generation of plants with altered oil content
12/15/2005CA2567983A1 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics
12/15/2005CA2567887A1 Method for screening and compositions for treating cancers
12/15/2005CA2567805A1 Tgf derepressors and uses related thereto
12/15/2005CA2567728A1 Griffithsin, glycosylation-resistant griffithsin, and related conjugates,compositions, nucleic acids, vectors,host cells, methods of production and methods of use
12/15/2005CA2567655A1 Binding moieties based on shark ignar domains
12/15/2005CA2567449A1 Antibodies and related molecules that bind to psca proteins
12/15/2005CA2567309A1 Method of stabilizing proteins
12/15/2005CA2567111A1 Methods and agents for screening for compounds capable of modulating vegf expression
12/15/2005CA2567030A1 Stable peptide mimetic of hiv gp41 fusion intermediate
12/15/2005CA2566506A1 Peptides for inducing a ctl and/or htl response to hepatitis c virus
12/15/2005CA2565524A1 Splice variant of unc5h2
12/15/2005CA2563930A1 Method for activating of t cell protein tyrosine phosphatase and therapeutical methods based thereon
12/15/2005CA2563691A1 Cell death modulation via antagonists of fasl and fas activation
12/15/2005CA2562940A1 Methods of promoting cardiac cell proliferation
12/14/2005EP1605064A1 HIV Variant showing a novel resistance mechanism against protease inhibitors, diagnostic assays for detecting the variant, and methods for identifying drugs effective against the resistant virus
12/14/2005EP1605061A1 Neisseria genomic sequences and methods of their use
12/14/2005EP1605055A1 Method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same
12/14/2005EP1605054A1 Method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same
12/14/2005EP1605053A1 Use of adenoviruses mutated in the VA genes for cancer treatment
12/14/2005EP1605052A2 A method for producing influenza hemagglutinin multivalent vaccines
12/14/2005EP1605047A1 Chimeric and/or growth-restricted flaviviruses
12/14/2005EP1605046A1 Stably transfected cell lines expressing human GABA-A receptors with the subunit combination alpha-2, beta-3 and gamma-2
12/14/2005EP1605045A2 Polypeptides and nucleic acids encoding same
12/14/2005EP1605044A2 Marker for detecting mesenchymal stem cell and method of distinguishing mesenchymal stem cell using the marker
12/14/2005EP1605042A2 Compositions for protein fragment complementation assays to detect biomolecular interactions
12/14/2005EP1604996A2 An allergenic protein complex of natural rubber latex
12/14/2005EP1604688A1 Stabilised mRNA with increased G/C-content and optimised codon usage for gene therapy
12/14/2005EP1604685A2 An attenuated japanese encephalitis virus
12/14/2005EP1604684A1 Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens
12/14/2005EP1604210A2 Method for detecting alzheimer's disease and corresponding peptides and detection reagents
12/14/2005EP1604041A1 Screening assays for targets and drugs useful in treatment and prevention of lipid metabolism disorders
12/14/2005EP1604032A2 Method for detecting prognosis of cancer
12/14/2005EP1604029A2 Method for increasing resistance against stress factors in plants
12/14/2005EP1604028A2 Enhanced amylose production in plants
12/14/2005EP1604020A2 Method to confer cell culture replication activity to different hepatitis c virus isolates
12/14/2005EP1604015A1 METHOD FOR PRODUCING TARGET PROTEINS BY DELETING OR AMPLIFYING ibpA AND/OR ibpB GENE CODING FOR INCLUSION BODY-ASSOCIATED PROTEINS
12/14/2005EP1604014A2 Gene expression in breast cancer
12/14/2005EP1604011A2 Methods for identifying compounds that modulate untranslated region-dependent gene expression and methods of using same
12/14/2005EP1604009A2 Method for identifying risk of melanoma and treatments thereof
12/14/2005EP1603951A1 Soluble hybrid prion proteins and their use in the diagnosis, prevention and treatment of transmissible spongiform encephalopathies
12/14/2005EP1603950A2 Mutant cholera holotoxin as an adjuvant and an antigen carrier protein
12/14/2005EP1603947A1 Diagnostics and therapeutics for diseases associated with g-protein coupled protease activated receptor 1 (par1)
12/14/2005EP1603946A1 Organic anion transporting (oat)-like protein ust3-like1 and uses thereof
12/14/2005EP1603945A2 Insulin-like growth factor (igf-i) plasmid-mediated supplementation for therapeutic applications
12/14/2005EP1603944A1 Amylin aggregation inhibitors and use thereof
12/14/2005EP1603943A2 Methods and compositions involving mda-7
12/14/2005EP1603941A1 Inhibitors of extracellular hsp90
12/14/2005EP1603940A2 Process for increasing rsv surface glycoprotein yields using a mutant strain of rsv
12/14/2005EP1603938A2 Inclusion bodies as antigens for the oral vaccination of animals against csfv
12/14/2005EP1603937A2 Peptides associated with hla-dr mhc class ii molecules involved in autoimmune diseases
12/14/2005EP1603931A2 Methods of evaluating glycomolecules for enhanced activities
12/14/2005EP1603591A2 Allergen peptide fragments and use thereof
12/14/2005EP1603590A2 Influenza virus vaccine
12/14/2005EP1603585A2 Polynucleotide encoding a novel human g-protein coupled receptor variant of hm74, hgprbmy74
12/14/2005EP1603391A1 Methods for using compositions comprising heat shock proteins or alpha-2-macroglobulin in the treatment of cancer and infectious disease
12/14/2005EP1599715A3 Autologous or homologous coagulant produced from anticoagulated whole blood
12/14/2005EP1581554A3 Novel t-cell proteins, peptides and antibodies derived therefrom and uses thereof
12/14/2005EP1527084A4 Promoters exhibiting endothelial cell specificity and methods of using same
12/14/2005EP1482969A4 Purifying process of soluble proteins of the l. obliqua bristles through prothrombin activation; process for a partial determination of the amino acids sequence of the prothrombin activator; process for determining the prothrombin activation of fraction ii, n-terminal and internal fragments sequence
12/14/2005EP1438410B1 Promoters to control cell differentiation
12/14/2005EP1379691A4 Differentially methylated sequences in pancreatic cancer
1 ... 1113 1114 1115 1116 1117 1118 1119 1120 1121 1122 1123 1124 1125 1126 1127 1128 1129 1130 1131 1132 1133 ... 2916